US 11,723,963 B2
Peptide analogs capable of enhancing stimulation of a glioma-specific CTL response
Hideho Okada, Pittsburgh, PA (US); and Walter J. Storkus, Glenshaw, PA (US)
Assigned to UNIVERSITY OF PITTSBURGH—OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION, Pittsburgh, PA (US)
Filed by University of Pittsburgh—Of the Commonwealth System of Higher Education, Pittsburgh, PA (US)
Filed on Sep. 16, 2019, as Appl. No. 16/572,019.
Application 16/572,019 is a continuation of application No. 15/205,203, filed on Jul. 8, 2016, granted, now 10,434,155.
Application 15/205,203 is a continuation of application No. 14/951,821, filed on Nov. 25, 2015, abandoned.
Application 14/951,821 is a continuation of application No. 14/688,376, filed on Apr. 16, 2015, abandoned.
Application 14/688,376 is a continuation of application No. 14/478,458, filed on Sep. 5, 2014, abandoned.
Application 14/478,458 is a continuation of application No. 12/561,973, filed on Sep. 17, 2009, granted, now 8,859,488, issued on Oct. 14, 2014.
Application 12/561,973 is a continuation of application No. 11/231,618, filed on Sep. 21, 2005, granted, now 7,612,162, issued on Nov. 3, 2009.
Claims priority of provisional application 60/611,797, filed on Sep. 21, 2004.
Prior Publication US 2020/0246442 A1, Aug. 6, 2020
This patent is subject to a terminal disclaimer.
Int. Cl. A61K 39/00 (2006.01); C07K 14/715 (2006.01); A61K 38/00 (2006.01)
CPC A61K 39/0011 (2013.01) [C07K 14/7155 (2013.01); A61K 38/00 (2013.01); A61K 2039/55516 (2013.01); A61K 2039/572 (2013.01)] 8 Claims
 
1. A composition comprising a peptide consisting of the amino acid sequence of ALPFGFILV (SEQ ID NO: 3), a peptide consisting of the amino acid sequence of TLADFDPRV (SEQ ID NO: 6), and a physiologically-acceptable carrier.